The mRNA structure has potent regulatory effects on type 2 iodothyronine deiodinase expression

Molecular Endocrinology

Volumn 16, Issue 7, 2002, Pages 1667-1679

  Gereben, Balázs ^a,e   Kollár, Anna ^b,d   Harney, John W ^c,f   ReedLarsen, P ^a,f  

^a Institute of Experimental Medicine   (United States)

^b Department of Neurobiology ^*  (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d SZENT ISTVÁN UNIVERSITY   (Hungary)

^e Diabet Hypertension Brigham W   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROXINE DEIODINASE; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE II; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CATALYSIS; CHICKEN; DRUG POTENCY; ENZYME REGULATION; GENE DELETION; HUMAN; HUMAN TISSUE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RNA STRUCTURE; START CODON; TRANSCRIPTION REGULATION; 3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANIMAL; CELL CULTURE; CHEMISTRY; CONFORMATION; GENE EXPRESSION REGULATION; GENETICS; HALF LIFE TIME; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; RNA PROCESSING; TRANSPOSON;

ANIMALIA; GALLUS GALLUS; VERTEBRATA;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CHICKENS; CLONING, MOLECULAR; CODON, INITIATOR; DNA TRANSPOSABLE ELEMENTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HALF-LIFE; HUMANS; IODIDE PEROXIDASE; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEIC ACID CONFORMATION; PROTEIN BIOSYNTHESIS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER;

EID: 85047684915     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.16.7.0879     Document Type: Article

References (50)

1. Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues
2. Biochemistry, cellular and molecular biology and physiological roles of the iodothyronine selenodeiodinases
3. Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3′ untranslated region
4. The role of selenocysteine 133 in catalysis by the human type 2 iodothyronine deiodinase
5. Expression of the type II iodothyronine deiodinase in cultured rat astrocytes is selenium-dependent
6. The human type 2 iodothyronine deiodinase is a selenoprotein highly expressed in a mesothelioma cell line
7. Decoding apparatus for eukaryotic selenocysteine incorporation
8. Molecular biological and biochemical characterization of the human type 2 selenodeiodinase
9. Type 2 iodothyronine deiodinase is highly expressed in human thyroid
10. Expression and regulation of type II iodothyronine deiodinase in human thyroid gland
11. Characterization of the 5′-flanking and 5′-untranslated regions of the cyclic adenosine 3′,5′-monophosphate-responsive human type 2 iodothyronine deiodinase gene
12. The human, but not rat, dio2 gene is stimulated by thyroid transcription factor-1 (TTF-1)
13. Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms
14. Studies of the hormonal regulation of type 2 5′-iodothyronine deiodinase messenger ribonucleic acid in pituitary tumor cells using semiquantitative reverse transcription-polymerase chain reaction
15. Tissue-specific transgenic knockdown of fos-related antigen 2 (fra-2) expression mediated by dominant negative fra-2
16. Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes
17. Substrate-induced down-regulation of human type 2 deiodinase (hD2) is mediated through proteasomal degradation and requires interaction with the enzyme's active center
18. Selective proteolysis of human type 2 deiodinase: A novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation
19. The 3′-untranslated region of human type 2 iodothyronine deiodinase mRNA contains a functional selenocysteine insertion sequence element
20. Cloning of a 5.8 kb cDNA for a mouse type 2 deiodinase
21. Cloning and expression of the chicken type 2 iodothyronine 5′-deiodinase
22. Translational termination efficiency in mammals is influenced by the base following the stop codon
23. AU-rich elements: Characterization and importance in mRNA degradation
24. Translational control of GCN4: An in vivo barometer of initiation-factor activity
25. The leader peptide of yeast gene CPA1 is essential for the translational repression of its expression
26. Internal initiation of translation in eukaryotes: The picornavirus paradigm and beyond
27. Initiation codons within 5′-leaders of mRNAs as regulators of translation
28. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs
29. An analysis of vertebrate mRNA sequences: Intimations of translational control
30. Translational regulation of angiotensin II type 1A receptor. Role of upstream AUG triplets
31. Inhibition of CCAAT/enhancer-binding protein α and β translation by upstream open reading frames
32. Regulation of rat ornithine decarboxylase mRNA translation by its 5′-untranslated region
33. Biosynthesis of human fibroblast growth factor-5
34. Posttranscriptional regulation of human ADH5/FDH and Myf6 gene expression by upstream AUG codons
35. Translational control of mammalian serine hydroxymethyltransferase expression
36. Translational control by an upstream open reading frame in the HER-2/neu transcript
37. The peptide product of a 5′ leader cistron in the β2 adrenergic receptor mRNA inhibits receptor synthesis
38. Polymorphisms of the 5′ leader cistron of the human beta2-adrenergic receptor regulate receptor expression
39. Influences of mRNA secondary structure on initiation by eukaryotic ribosomes
40. Type-II thyroxine 5′-deiodinase is present in the rat pineal gland
41. Pretranslational regulation of rhythmic type II iodothyronine deiodinase expression by β-adrenergic mechanism in the rat pineal gland
42. Type 2 iodothyronine deiodinase expression in the cochlea before the onset of hearing
43. Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons
44. Isolation and characterization of the 5′-upstream and untranslated regions of the mouse type II iodothyronine deiodinase gene
45. Identification of two novel splicing variants of human type II iodothyronine deiodinase mRNA
46. Functional characterization of the rat growth hormone promoter elements required for induction by thyroid hormone with and without a co-transfected β type thyroid hormone receptor
47. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
48. Selenocysteine incorporation in eukaryotes: Insights into mechanism and efficiency from sequence, structure, and spacing proximity studies of the type 1 deiodinase SECIS element
49. Functionality of mutations at conserved nucleotides in eukaryotic SECIS elements is determined by the identify of a single non-conserved nucleotide
50. Multiple sequences encoding potential thyroid hormone receptors isolated from mouse skeletal muscle cDNA libraries